These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 29875212)

  • 1. Clinical trial design and dissemination: comprehensive analysis of clinicaltrials.gov and PubMed data since 2005.
    Zwierzyna M; Davies M; Hingorani AD; Hunter J
    BMJ; 2018 Jun; 361():k2130. PubMed ID: 29875212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compliance with results reporting at ClinicalTrials.gov.
    Anderson ML; Chiswell K; Peterson ED; Tasneem A; Topping J; Califf RM
    N Engl J Med; 2015 Mar; 372(11):1031-9. PubMed ID: 25760355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial registration, reporting, publication and FDAAA compliance: a cross-sectional analysis and ranking of new drugs approved by the FDA in 2012.
    Miller JE; Korn D; Ross JS
    BMJ Open; 2015 Nov; 5(11):e009758. PubMed ID: 26563214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential citation rates of major cardiovascular clinical trials according to source of funding: a survey from 2000 to 2005.
    Conen D; Torres J; Ridker PM
    Circulation; 2008 Sep; 118(13):1321-7. PubMed ID: 18779441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007-2010.
    Califf RM; Zarin DA; Kramer JM; Sherman RE; Aberle LH; Tasneem A
    JAMA; 2012 May; 307(17):1838-47. PubMed ID: 22550198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of funding of clinical trials: cross-sectional survey and proposed guidance.
    Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA
    BMJ Open; 2017 Oct; 7(10):e015997. PubMed ID: 28982811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of funding source on effect size in randomized controlled trials: 2013-2015 - a cross-sectional survey and meta-analysis.
    Falk Delgado A; Falk Delgado A
    Trials; 2017 Mar; 18(1):125. PubMed ID: 28292317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring clinical trial transparency: an empirical analysis of newly approved drugs and large pharmaceutical companies.
    Miller JE; Wilenzick M; Ritcey N; Ross JS; Mello MM
    BMJ Open; 2017 Dec; 7(12):e017917. PubMed ID: 29208616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome reporting among drug trials registered in ClinicalTrials.gov.
    Bourgeois FT; Murthy S; Mandl KD
    Ann Intern Med; 2010 Aug; 153(3):158-66. PubMed ID: 20679560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of industry collaboration on randomised controlled trials in oncology.
    Linker A; Yang A; Roper N; Whitaker E; Korenstein D
    Eur J Cancer; 2017 Feb; 72():71-77. PubMed ID: 28027518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Ophthalmology Trials Registered in ClinicalTrials.gov, 2007-2018.
    Turner B; Rajeshuni N; Tran EM; Ludwig CA; Tauqeer Z; Weeks B; Kinde B; Pershing S
    Am J Ophthalmol; 2020 Mar; 211():132-141. PubMed ID: 31730839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis.
    Ross JS; Tse T; Zarin DA; Xu H; Zhou L; Krumholz HM
    BMJ; 2012 Jan; 344():d7292. PubMed ID: 22214755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical trial transparency update: an assessment of the disclosure of results of company-sponsored trials associated with new medicines approved in Europe in 2014.
    Deane BR; Porkess S
    Curr Med Res Opin; 2018 Jul; 34(7):1239-1243. PubMed ID: 29219621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Oncology Trial Results Reporting Over a 10-Year Period.
    Liu X; Zhang Y; Li WF; Vokes E; Sun Y; Le QT; Ma J
    JAMA Netw Open; 2021 May; 4(5):e2110438. PubMed ID: 34028549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The uncertainty principle and industry-sponsored research.
    Djulbegovic B; Lacevic M; Cantor A; Fields KK; Bennett CL; Adams JR; Kuderer NM; Lyman GH
    Lancet; 2000 Aug; 356(9230):635-8. PubMed ID: 10968436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Publication status of contemporary oncology randomised controlled trials worldwide.
    Chen YP; Liu X; Lv JW; Li WF; Zhang Y; Guo Y; Lin AH; Sun Y; Mao YP; Ma J
    Eur J Cancer; 2016 Oct; 66():17-25. PubMed ID: 27522246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Cancer Literature Reflect Multidisciplinary Practice? A Systematic Review of Oncology Studies in the Medical Literature Over a 20-Year Period.
    Holliday EB; Ahmed AA; Yoo SK; Jagsi R; Hoffman KE
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):721-31. PubMed ID: 26104927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance on Mandatory Data Reporting in Registered Obstetrics Trials.
    Checketts JX; Evans MB; Athale AH; Jawhar OM; Wright MR; Bryant K; Vassar M
    Am J Perinatol; 2018 Oct; 35(12):1192-1196. PubMed ID: 29695018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Trends in the Design, Accrual, and Completion of Trials Registered in ClinicalTrials.gov by Sponsor Type, 2000-2019.
    Gresham G; Meinert JL; Gresham AG; Meinert CL
    JAMA Netw Open; 2020 Aug; 3(8):e2014682. PubMed ID: 32845329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fate of prospective spine studies registered on www.ClinicalTrials.gov.
    Ohnmeiss DD
    Spine J; 2015 Mar; 15(3):487-91. PubMed ID: 25315132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.